FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/059991 [Registered on: 20/11/2023] Trial Registered Prospectively
Last Modified On: 16/11/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparision of blood product and polymer solution included blood product for the treatment of jaw joint problem. 
Scientific Title of Study   Comparison of Injectable Platelet-Rich Fibrin and Hyaluronic Acid Combination versus Injectable Platelet-Rich Fibrin Only in Internal Derangement Of Temporomandibular Joint: A Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Malya Manoj Kumar Naik 
Designation  Post Graduate Student 
Affiliation  Vishnu Dental College 
Address  Department Of Oral And Maxillofacial Surgery Block-3 Room No-2 Vishnu Dental College Vishnupur Bhimavaram

West Godavari
ANDHRA PRADESH
534202
India 
Phone  9490734248  
Fax    
Email  mimanojkumar21@gmaiil.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr U ShivajI Raju 
Designation  Professor 
Affiliation  Vishnu Dental College 
Address  Department of Oral and Maxillofacial Surgery Block-3 Room No-2 Vishnu Dental College Vishnupur Bhimavaram

West Godavari
ANDHRA PRADESH
534202
India 
Phone  9966351997  
Fax    
Email  shivajiraju.u@vdc.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Kishore Moturi 
Designation  Professor 
Affiliation  Vishnu Dental College 
Address  Department of Oral and Maxillofacial Surgery Block-3 Room No-2 Vishnu Dental College Vishnupur Bhimavaram

West Godavari
ANDHRA PRADESH
534202
India 
Phone  9849094159  
Fax    
Email  kishoremoturi@vdc.edu.in  
 
Source of Monetary or Material Support  
Vishnu Dental College,Vishnupur,Bhimavaram 
 
Primary Sponsor  
Name  Malya Manoj Kumar Naik 
Address  Block 3,Room No 2,Department Of Oral And Maxillofacial Surgery, Vishnu Dental College Vishnupur Bhimavaram West Godavari ANDHRA PRADESH 534202 India  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Malya Manoj Kumar Naik  Vishnu Dental College  Department of Oral and Maxillofacial Surgery block-3 room no-2 Vishnu Dental College Vishnupur Bhimavaram
West Godavari
ANDHRA PRADESH 
9490734248

mimanojkumar21@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE VISHNU DENTAL COLLEGE, BHIMAVARAM   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M248||Other specific joint derangements,not elsewhere classified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Injectable Platelet-Rich Fibrin   1ml of I-PRF which is prepared from 10 ml of patient whole blood will be injected into temporomandibular joint space using needle. 
Intervention  Injectable Platelet-Rich Fibrin and Hyaluronic Acid Combination.  0.5 ml of Commercially available Hyaluronic acid (Hyalgan 20gm/2ml,FIDIA) will be added to 1ml of I-PRF which is prepared from 10 ml of patient whole blood in a separate plastic test tube and thus formed 1.5 ml of homogenate solution will be injected into upper temporomandibular joint space using needle. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients in the age group of 18-60 years.
2.Patients diagnosed with Wilkes stage II and III of ID of temporomandibular joint.
3.Patients not responding to conservative treatments.
4.Willingness to participate in the study and to give informed consent.
5.Willing for a minimum 6-month follow-up after undergoing treatment. 
 
ExclusionCriteria 
Details  1.Any systemic or malignant disease that could interfere with the TMJ treatment or assessment.
2.History of Previous TMJ surgery/condylar trauma.
3.Failure during intra-articular injection procedure.
4.Fibrous or osseous ankylosis of the TMJ.
5.Cutaneous, otic, or articular infections.
6.Edentulous patients.
7.Pregnant and breastfeeding.
8.Bilateral TMJ pain.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Pain at rest & chewing, assessed by means of a visual analog scale.
2.Mandibular range of movement, comprising maximum non assisted & assisted mouth opening, left & right laterotrusion, & protrusion movements.
3.Clicking by Auscultation.
4.QOL questionnaire.
5.Functional limitation during usual jaw movements. 
1.Pain at rest & chewing at 1 Week,1 month,3 months,6 months postoperative.
2.Mandibular range of movement, comprising maximum non assisted & assisted mouth opening, left & right laterotrusion, & protrusion movements at 1 Week,1 month,3 months,6 months postoperative.
3.Clicking at 1 Week,1 month,3 months,6 months postoperative.
4.QOL questionnaire at 1 Week,1 month,3 months,6 months postoperative.
5.Functional limitation at 1 Week,1 month,3 months,6 months postoperative. 
 
Secondary Outcome  
Outcome  TimePoints 
1.Pain at rest & chewing, assessed by means of a visual analog scale.
2.Mandibular range of movement, comprising maximum non assisted & assisted mouth opening, left & right laterotrusion, & protrusion movements.
3.Clicking by Auscultation.
4.QOL questionnaire.
5.Functional limitation during usual jaw movements. 
1.Pain at rest & chewing at 1 Week,1 month,3 months,6 months postoperative.
2.Mandibular range of movement, comprising maximum non assisted & assisted mouth opening, left & right laterotrusion, & protrusion movements at 1 Week,1 month,3 months,6 months postoperative.
3.Clicking at 1 Week,1 month,3 months,6 months postoperative.
4.QOL questionnaire at 1 Week,1 month,3 months,6 months postoperative.
5.Functional limitation at 1 Week,1 month,3 months,6 months postoperative. 
 
Target Sample Size   Total Sample Size="28"
Sample Size from India="28" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The aim of the study is to investigate the efficacy of combination of Hyaluronic acid, I-PRF and I-PRF alone in patients with internal derangements of the temporomandibular joint (TMJ).A total of 28 patients with tmj internal derangement will be selected from outpatient department of oral and maxillofacial surgery,vishnu dental college,bhimavaram, and will be equally divided into 2 groups of 14 each.in group-A  arthrocentesis followed by i-prf injection and in group-B arthrocentesis followed by i-prf and hyaluronic acid combination.The study is interventional prospective study.computer generated randomization will be used  as sampling method.The following primary outcomes 
a) Pain at rest and chewing
b) Mandibular range of movement
c) Clicking
d) QOL questionnaire 
d)functional limitation 
will be measured at preoperative,1 week,1 month,3 months,6 months.
The data will be analyzed individually for all the patients.There is no conflict of interest.
 
Close